JPWO2023023131A5 - - Google Patents
Info
- Publication number
- JPWO2023023131A5 JPWO2023023131A5 JP2024509376A JP2024509376A JPWO2023023131A5 JP WO2023023131 A5 JPWO2023023131 A5 JP WO2023023131A5 JP 2024509376 A JP2024509376 A JP 2024509376A JP 2024509376 A JP2024509376 A JP 2024509376A JP WO2023023131 A5 JPWO2023023131 A5 JP WO2023023131A5
- Authority
- JP
- Japan
- Prior art keywords
- ifn
- prodrug
- inducible
- polypeptide
- protease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163234284P | 2021-08-18 | 2021-08-18 | |
| US63/234,284 | 2021-08-18 | ||
| PCT/US2022/040564 WO2023023131A2 (en) | 2021-08-18 | 2022-08-17 | Activatable inteferon polypeptides and methods of use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024531338A JP2024531338A (ja) | 2024-08-29 |
| JP2024531338A5 JP2024531338A5 (https=) | 2025-08-25 |
| JPWO2023023131A5 true JPWO2023023131A5 (https=) | 2025-08-25 |
Family
ID=83899708
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024509376A Pending JP2024531338A (ja) | 2021-08-18 | 2022-08-17 | 活性化可能インターフェロンポリペプチド及びその使用方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240216474A1 (https=) |
| EP (1) | EP4387987A2 (https=) |
| JP (1) | JP2024531338A (https=) |
| CN (1) | CN118119634A (https=) |
| CA (1) | CA3228927A1 (https=) |
| TW (1) | TW202321284A (https=) |
| WO (1) | WO2023023131A2 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021231773A1 (en) | 2020-05-13 | 2021-11-18 | Good Therapeutics, Inc. | Compositions of protein complexes and methods of use thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006110728A2 (en) | 2005-04-12 | 2006-10-19 | The Uab Research Foundation | Immunogenic cmv tegument aggregates |
| JP5861223B2 (ja) * | 2009-02-23 | 2016-02-16 | サイトムエックス セラピューティクス, インク.CytomX Therapeutics, Inc. | プロタンパク質およびその使用方法 |
| CN111050803A (zh) * | 2017-06-20 | 2020-04-21 | 德克萨斯大学系统董事会 | 用于治疗癌症的干扰素前药 |
| US20210130430A1 (en) * | 2018-05-14 | 2021-05-06 | Werewolf Therapeutics, Inc. | Activatable cytokine polypeptides and methods of use thereof |
| CN120463822A (zh) * | 2018-09-27 | 2025-08-12 | 西里欧发展公司 | 掩蔽型细胞因子多肽 |
| BR112022009110A2 (pt) * | 2019-11-14 | 2022-07-26 | Werewolf Therapeutics Inc | Polipeptídeos de citocina ativáveis e métodos de uso destes |
| US20210252142A1 (en) * | 2020-02-06 | 2021-08-19 | Aetio Biotherapy, Inc. | Compositions and methods for treating viral infections |
-
2022
- 2022-08-17 CN CN202280070171.4A patent/CN118119634A/zh active Pending
- 2022-08-17 CA CA3228927A patent/CA3228927A1/en active Pending
- 2022-08-17 EP EP22792938.7A patent/EP4387987A2/en active Pending
- 2022-08-17 JP JP2024509376A patent/JP2024531338A/ja active Pending
- 2022-08-17 WO PCT/US2022/040564 patent/WO2023023131A2/en not_active Ceased
- 2022-08-18 TW TW111131193A patent/TW202321284A/zh unknown
-
2024
- 2024-02-13 US US18/440,841 patent/US20240216474A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019513014A5 (https=) | ||
| JP2021087429A5 (https=) | ||
| US20210269530A1 (en) | Conditionally activated binding protein comprising a sterically occluded target binding domain | |
| US9540618B2 (en) | Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses | |
| US20220267400A1 (en) | Il-2 cytokine prodrugs comprising a cleavable linker | |
| JPWO2021097376A5 (https=) | ||
| FI3794024T3 (fi) | Aktivoitavia interleukiini-2-polypeptidejä ja niiden käyttömenetelmiä | |
| CN120248140A (zh) | 基质金属蛋白酶可裂解的和丝氨酸或半胱氨酸蛋白酶可裂解的底物及其使用方法 | |
| Lin et al. | Ab locks for improving the selectivity and safety of antibody drugs | |
| JP2018520642A5 (https=) | ||
| CN118165076A (zh) | 基质金属蛋白酶底物和其它可切割部分及其使用方法 | |
| WO2018097308A1 (ja) | リガンド結合活性が調整可能なリガンド結合分子 | |
| JP2023540533A (ja) | ヒト血清アルブミンドメインを有する、制約され、条件付きで活性化された結合タンパク質構築物 | |
| AU2021208553A1 (en) | Cytokine IL-2 prodrugs comprising a cleavable linker | |
| JPWO2021236676A5 (https=) | ||
| JPWO2023023131A5 (https=) | ||
| JPWO2022125576A5 (https=) | ||
| CN119462956A (zh) | 接头多肽 | |
| JPWO2022016270A5 (https=) | ||
| JP2024531338A (ja) | 活性化可能インターフェロンポリペプチド及びその使用方法 | |
| JPWO2023192606A5 (https=) | ||
| JPWO2023192973A5 (https=) | ||
| JPWO2022240637A5 (https=) | ||
| EP4402157B1 (en) | Cleavable linkers | |
| RU2023121219A (ru) | Активируемые полипептиды цитокинов и способы их применения |